Morgan Stanley (MS) Stock Forecast & Price Target

$197.70 +8.12 (+4.28%)

Closing price 05/20/2026 03:59 PM Eastern

Extended Trading

$197.12 -0.58 (-0.29%)

As of 06:32 AM Eastern

Compare

Morgan Stanley - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 24 Analyst Ratings

Sell
0

Hold
11

Buy
13

Based on 24 Wall Street analysts who have issued ratings for Morgan Stanley in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 24 analysts, 11 have given a hold rating, 12 have given a buy rating, and 1 has given a strong buy rating for MS.

Consensus Price Target

$205.95
4.17% Upside

According to the 24 analysts' twelve-month price targets for Morgan Stanley, the average price target is $205.95. The highest price target for MS is $230.00, while the lowest price target for MS is $177.00. The average price target represents a forecasted upside of 4.17% from the current price of $197.70.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for MS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Morgan Stanley and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MS Analyst Ratings Over Time

Type	Current Forecast 5/21/25 to 5/21/26	1 Month Ago 4/21/25 to 4/21/26	3 Months Ago 2/20/25 to 2/20/26	1 Year Ago 5/21/24 to 5/21/25
Strong Buy	1 Strong Buy rating(s)	0 Strong Buy rating(s)	3 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	12 Buy rating(s)	10 Buy rating(s)	7 Buy rating(s)	5 Buy rating(s)
Hold	11 Hold rating(s)	12 Hold rating(s)	9 Hold rating(s)	11 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$205.95	$201.33	$185.93	$132.46
Forecasted Upside	4.17% Upside	6.41% Upside	6.09% Upside	5.77% Upside
Consensus Rating	Moderate Buy	Hold	Moderate Buy	Hold

MS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Morgan Stanley Stock vs. The Competition

Type	Morgan Stanley	Finance Companies	Broader Market
Consensus Rating Score	2.58	2.31	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	4.17% Upside	29.45% Upside	16.44% Upside
News Sentiment Rating	Positive News See Recent MS News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/19/2026	CICC Research 4 of 5 stars		Boost Target	Outperform	$175.00 ➝ $200.00	+4.31%
5/8/2026	Citigroup 4 of 5 stars	Keith Horowitz 3 of 5 stars	Boost Target	Neutral	$170.00 ➝ $194.00	+1.93%
5/7/2026	Dbs Bank 5 of 5 stars		Boost Target		$185.00 ➝ $220.00	+14.62%
5/6/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erika Najarian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target		$196.00 ➝ $214.00	+11.20%
5/5/2026	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Neutral	$175.00 ➝ $198.00	+4.67%
4/28/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold ➝ Strong-Buy
4/27/2026	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold ➝ Buy
4/24/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Neutral	$195.00 ➝ $205.00	+9.26%
4/20/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$190.00 ➝ $220.00	+15.06%
4/17/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Neutral	$171.00 ➝ $183.00	-3.89%
Get the Latest News and Ratings for MS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Morgan Stanley and its competitors with MarketBeat's FREE daily newsletter.
4/17/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Hold	$153.00 ➝ $177.00	-7.04%
4/16/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Mayo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$189.00 ➝ $200.00	+4.43%
4/16/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Ramsden Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$186.00 ➝ $205.00	+7.04%
4/16/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Goldberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$219.00 ➝ $230.00	+20.09%
4/16/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gerard Cassidy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Sector Perform	$207.00	+9.49%
4/16/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$190.00 ➝ $210.00	+9.76%
4/16/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$210.00 ➝ $225.00	+17.60%
4/16/2026	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin Ryan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Perform
4/16/2026	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher McGratty Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$210.00 ➝ $218.00	+13.83%
4/16/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ebrahim Poonawala Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$220.00 ➝ $225.00	+17.48%
4/1/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Outperform	$221.00 ➝ $197.00	+18.55%
3/10/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kian Abouhossein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$173.00 ➝ $179.00	+11.17%
3/9/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Fannon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
1/22/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy (B-)
7/17/2024	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 06:29 AM ET.

Should I Buy Morgan Stanley Stock? MS Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, May 20, 2026. Please send any questions or comments about these Morgan Stanley pros and cons to contact@marketbeat.com.

Morgan Stanley
Bull Case

Here are some ways that investors could benefit from investing in Morgan Stanley:

The current stock price is around $189.58, which reflects a strong performance in the financial services sector.
Recent quarterly earnings showed an EPS of $3.43, exceeding analyst expectations, indicating robust profitability.
The company reported a revenue increase of 16.0% compared to the same quarter last year, showcasing strong growth potential.
Morgan Stanley has a solid dividend yield of 2.1%, providing a steady income stream for investors.
With a market cap of approximately $299.02 billion, Morgan Stanley is well-positioned in the market, suggesting stability and reliability.

Morgan Stanley
Bear Case

Investors should be bearish about investing in Morgan Stanley for these reasons:

The firm has warned that a bond selloff could lead to a significant stock-market correction, which may impact stock performance.
Insider selling activity has been noted, with a recent sale of 14,690 shares, which could signal a lack of confidence among executives.
Only 0.17% of the stock is owned by corporate insiders, indicating limited insider investment in the company.
The current debt-to-equity ratio of 3.52 suggests a high level of debt compared to equity, which could pose risks in a rising interest rate environment.
Market sentiment is mixed, with caution surrounding potential economic downturns that could affect financial services firms like Morgan Stanley.

MS Forecast - Frequently Asked Questions

According to the research reports of 24 Wall Street equities research analysts, the average twelve-month stock price forecast for Morgan Stanley is $205.95, with a high forecast of $230.00 and a low forecast of $177.00.

24 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Morgan Stanley in the last twelve months. There are currently 11 hold ratings, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" MS shares.

According to analysts, Morgan Stanley's stock has a predicted upside of 4.17% based on their 12-month stock forecasts.

Over the previous 90 days, Morgan Stanley's stock had 3 upgrades and 2 downgrades by analysts.

Morgan Stanley has been rated by research analysts at Argus, Bank of America, Barclays, BMO Capital Markets, BNP Paribas Exane, CICC Research, Citigroup, Citizens Jmp, Daiwa Securities Group, Dbs Bank, Erste Group Bank, Evercore, HSBC, Jefferies Financial Group, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Rothschild & Co Redburn, Royal Bank Of Canada, The Goldman Sachs Group, UBS Group, Wells Fargo & Company, Wolfe Research, and Zacks Research in the past 90 days.

Morgan Stanley also publishes sell-side equities research reports and recommendations about other companies, which can be viewed at its brokerage rating page.

Analysts like Morgan Stanley more than other "finance" companies. The consensus rating for Morgan Stanley is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how MS compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Morgan Stanley Recommendations

This page (NYSE:MS) was last updated on 5/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Morgan Stanley (MS) Stock Forecast & Price Target

Morgan Stanley - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

MS Analyst Ratings Over Time

MS Analyst Recommendations By Month

MS Price Targets by Month

Morgan Stanley Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Morgan Stanley Stock? MS Pros and Cons Explained

Morgan Stanley
Bull Case

Morgan Stanley
Bear Case

MS Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Morgan Stanley Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Morgan Stanley (MS) Stock Forecast & Price Target

Morgan Stanley - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

MS Analyst Ratings Over Time

MS Analyst Recommendations By Month

MS Price Targets by Month

Morgan Stanley Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Morgan Stanley Stock? MS Pros and Cons Explained

Morgan Stanley Bull Case

Morgan Stanley Bear Case

MS Forecast - Frequently Asked Questions

What is Morgan Stanley's forecast for 2026?

Should I buy or sell Morgan Stanley stock right now?

Does Morgan Stanley's stock price have much upside?

Has Morgan Stanley been upgraded or downgraded by Wall Street analysts recently?

What analysts cover Morgan Stanley?

Does Morgan Stanley rate other companies?

Do Wall Street analysts like Morgan Stanley more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Morgan Stanley Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Morgan Stanley
Bull Case

Morgan Stanley
Bear Case